Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

A new study finds that oral ketamine significantly reduces PTSD symptoms, with 73% of participants seeing a 50% reduction in ...

Ketamine is a short-acting anesthetic that has been used for decades in medical settings. In recent years, researchers have ...

“Ketamine felt like a giant exhale ... and then what I had, which is an injection in the muscle, which puts you over the edge very quickly,” he told Yahoo Life in 2023. Baltierra explained ...

That’s when LaMere, who was allegedly the paramedic in charge and the only person on scene qualified to administer medication ...

Why We Need Fast-Acting Anxiety Relief Now More Than Ever Anxiety isn’t just feeling nervous before a big event—it can be relentless, overwhelming, and even debilitating. Traditional treatments like ...

Hydroponic weed, gold and diamonds worth more than Rs 50 crore were seized at the Mumbai airport and and eight persons have ...

According to a new study, ketamine use has risen significantly since 2015. The results highlight the need for closer monitoring of recreational ketamine use. A recent study analyzing data from the ...

Start your Independent Premium subscription today. Ketamine was previously reclassified from class C to class B in 2014, and since then, the number of users has continued to rise. The most recent ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...